3. Under the supposition that the price computed by Manhattan Pharmaceuticals, Inc. using Wyant’s criterion is greater than $0.03, the factors that Manhattan’s management should consider before deciding whether or not to submit a bid at the maximum allowable price include whether Manhattan Pharmaceuticals has excess capacity, whether there are available jobs on which earnings might be greater, and whether the maximum bid of $0.03 contributes toward covering fixed costs.